{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/G",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "GENITO URINARY SYSTEM AND SEX HORMONES" , "@language" : "en" } ,        { "@value" : "Urogenit\u00E1ln\u00ED trakt a pohlavn\u00ED hormony" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Jin\u00E1 gynekologika" , "@language" : "cs" } ,        { "@value" : "OTHER GYNECOLOGICALS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G02C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Jin\u00E1 gynekologika" , "@language" : "cs" } ,        { "@value" : "OTHER GYNECOLOGICALS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G02C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G02CB",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Prolactine inhibitors" , "@language" : "en" } ,        { "@value" : "Inhibitory prolaktinu" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G02CB" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G02CB03",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/G02CB" ,        "http://linked.opendata.cz/resource/ATC/G" ,        "http://linked.opendata.cz/resource/ATC/G02" ,        "http://linked.opendata.cz/resource/ATC/G02C" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cabergoline" , "@language" : "en" } ,        { "@value" : "Kabergolin" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G02CB03" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001610",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hypersensitivity" , "@language" : "en" } ,        { "@value" : "Alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001616",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hypertension" , "@language" : "en" } ,        { "@value" : "Hypertenze" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0136060",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Cabergoline" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000001616" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001610" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/DOSTINEX-0-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0136060" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DOSTINEX 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G02CB03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025274" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025273" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025274",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DOSTINEX 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G02CB03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "GYNAECOLOGICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC138762_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "2" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Inhibice/potla\u010Den\u00ED fyziologick\u00E9ho procesu laktace.\nDOSTINEX je indikov\u00E1n k\u00A0z\u00E1bran\u011B n\u00E1stupu fyziologick\u00E9ho procesu laktace (pokud je pod\u00E1n t\u011Bsn\u011B po porodu) nebo k potla\u010Den\u00ED laktace ji\u017E rozvinut\u00E9:\n1) Po porodu, rozhodne li se matka d\u00EDt\u011B nekojit nebo v\u00A0p\u0159\u00EDpadech, kdy je kojen\u00ED kontraindikov\u00E1no pro l\u00E9ka\u0159sky opodstatn\u011Bn\u00E9 p\u0159ek\u00E1\u017Eky na stran\u011B matky nebo novorozence.\n2) V\u00A0p\u0159\u00EDpadech narozen\u00ED mrtv\u00E9ho d\u00EDt\u011Bte nebo po potratu.\nDOSTINEX p\u0159edch\u00E1z\u00ED rozvoji procesu laktace nebo jej potla\u010Duje t\u00EDm, \u017Ee inhibuje sekreci prolaktinu. V\u00A0proveden\u00FDch kontrolovan\u00FDch klinick\u00FDch pokusech se DOSTINEX, podan\u00FD v\u00A0jedin\u00E9 d\u00E1vce 1 mg b\u011Bhem prvn\u00EDho dne po porodu, u 70-90% \u017Een uk\u00E1zal jako \u00FA\u010Dinn\u00FD prost\u0159edek k\u00A0dosa\u017Een\u00ED inhibice sekrece ml\u00E9ka a tak\u00E9 k\u00A0potla\u010Den\u00ED puerper\u00E1ln\u00EDho p\u0159ekrven\u00ED a bolestivosti prs\u016F. Symptomy tzv. rebound-fenom\u00E9nu ve t\u0159et\u00EDm poporodn\u00EDm t\u00FDdnu se vyskytly u prs\u016F m\u00E9n\u011B ne\u017E 5% \u017Een (a vesm\u011Bs jen v\u00A0lehk\u00E9 intenzit\u011B).\nTerapie poruch spojen\u00FDch s hyperprolaktin\u00E9mi\u00ED\nDOSTINEX je indikov\u00E1n k l\u00E9\u010Db\u011B dysfunkc\u00ED souvisej\u00EDc\u00EDch s hyperprolaktin\u00E9mi\u00ED, zahrnuj\u00EDc\u00ED amenoreu, oligomenoreu, anovulaci a galaktoreu.\nDOSTINEX je indikov\u00E1n u pacient\u016F s hypofyz\u00E1rn\u00EDmi adenomy secernuj\u00EDc\u00EDmi prolaktin (mikro- a makroprolaktinadenomy), u stav\u016F idiopatick\u00E9 hyperprolaktin\u00E9mie nebo u syndromu pr\u00E1zdn\u00E9 selly spojen\u00E9 s hyperprolaktin\u00E9mi\u00ED, kter\u00E1 p\u0159edstavuje z\u00E1kladn\u00ED patologick\u00FD substr\u00E1t v\u0161ech v\u00FD\u0161e zm\u00EDn\u011Bn\u00FDch klinick\u00FDch projev\u016F.\nP\u0159i dlouhodob\u00E9 aplikaci byl DOSTINEX v\u00A0d\u00E1vkov\u00E9m rozmez\u00ED 1-2 mg t\u00FDdn\u011B \u00FA\u010Dinn\u00FD v\u00A0normalizaci s\u00E9rov\u00E9 prolaktin\u00E9mie u asi 84% hyperprolaktin\u00E9mick\u00FDch pacient\u016F. U 83% \u017Een, trp\u00EDc\u00EDch amenoreou, se poda\u0159ilo dos\u00E1hnout n\u00E1vratu pravideln\u00E9ho menstrua\u010Dn\u00EDho krv\u00E1cen\u00ED.\nU 89% \u017Een, u nich\u017E byly b\u011Bhem lute\u00E1ln\u00ED f\u00E1ze monitorov\u00E1ny hladiny progesteronu, bylo prok\u00E1z\u00E1no \u00FAsp\u011B\u0161n\u00E9 obnoven\u00ED ovula\u010Dn\u00EDch cykl\u016F. U 90% \u017Een, trp\u00EDc\u00EDch galaktoreou, bylo dosa\u017Eeno terapeutick\u00E9ho efektu. U 50-90% \u017Een i mu\u017E\u016F s\u00A0mikro nebo makroprolaktinomy se poda\u0159ilo l\u00E9\u010Dbou redukovat n\u00E1dorovou masu.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 272.7999877929688 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 170.3899993896484 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 2X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025273",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DOSTINEX 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G02CB03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "GYNAECOLOGICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC138762_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "8" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Inhibice/potla\u010Den\u00ED fyziologick\u00E9ho procesu laktace.\nDOSTINEX je indikov\u00E1n k\u00A0z\u00E1bran\u011B n\u00E1stupu fyziologick\u00E9ho procesu laktace (pokud je pod\u00E1n t\u011Bsn\u011B po porodu) nebo k potla\u010Den\u00ED laktace ji\u017E rozvinut\u00E9:\n1) Po porodu, rozhodne li se matka d\u00EDt\u011B nekojit nebo v\u00A0p\u0159\u00EDpadech, kdy je kojen\u00ED kontraindikov\u00E1no pro l\u00E9ka\u0159sky opodstatn\u011Bn\u00E9 p\u0159ek\u00E1\u017Eky na stran\u011B matky nebo novorozence.\n2) V\u00A0p\u0159\u00EDpadech narozen\u00ED mrtv\u00E9ho d\u00EDt\u011Bte nebo po potratu.\nDOSTINEX p\u0159edch\u00E1z\u00ED rozvoji procesu laktace nebo jej potla\u010Duje t\u00EDm, \u017Ee inhibuje sekreci prolaktinu. V\u00A0proveden\u00FDch kontrolovan\u00FDch klinick\u00FDch pokusech se DOSTINEX, podan\u00FD v\u00A0jedin\u00E9 d\u00E1vce 1 mg b\u011Bhem prvn\u00EDho dne po porodu, u 70-90% \u017Een uk\u00E1zal jako \u00FA\u010Dinn\u00FD prost\u0159edek k\u00A0dosa\u017Een\u00ED inhibice sekrece ml\u00E9ka a tak\u00E9 k\u00A0potla\u010Den\u00ED puerper\u00E1ln\u00EDho p\u0159ekrven\u00ED a bolestivosti prs\u016F. Symptomy tzv. rebound-fenom\u00E9nu ve t\u0159et\u00EDm poporodn\u00EDm t\u00FDdnu se vyskytly u prs\u016F m\u00E9n\u011B ne\u017E 5% \u017Een (a vesm\u011Bs jen v\u00A0lehk\u00E9 intenzit\u011B).\nTerapie poruch spojen\u00FDch s hyperprolaktin\u00E9mi\u00ED\nDOSTINEX je indikov\u00E1n k l\u00E9\u010Db\u011B dysfunkc\u00ED souvisej\u00EDc\u00EDch s hyperprolaktin\u00E9mi\u00ED, zahrnuj\u00EDc\u00ED amenoreu, oligomenoreu, anovulaci a galaktoreu.\nDOSTINEX je indikov\u00E1n u pacient\u016F s hypofyz\u00E1rn\u00EDmi adenomy secernuj\u00EDc\u00EDmi prolaktin (mikro- a makroprolaktinadenomy), u stav\u016F idiopatick\u00E9 hyperprolaktin\u00E9mie nebo u syndromu pr\u00E1zdn\u00E9 selly spojen\u00E9 s hyperprolaktin\u00E9mi\u00ED, kter\u00E1 p\u0159edstavuje z\u00E1kladn\u00ED patologick\u00FD substr\u00E1t v\u0161ech v\u00FD\u0161e zm\u00EDn\u011Bn\u00FDch klinick\u00FDch projev\u016F.\nP\u0159i dlouhodob\u00E9 aplikaci byl DOSTINEX v\u00A0d\u00E1vkov\u00E9m rozmez\u00ED 1-2 mg t\u00FDdn\u011B \u00FA\u010Dinn\u00FD v\u00A0normalizaci s\u00E9rov\u00E9 prolaktin\u00E9mie u asi 84% hyperprolaktin\u00E9mick\u00FDch pacient\u016F. U 83% \u017Een, trp\u00EDc\u00EDch amenoreou, se poda\u0159ilo dos\u00E1hnout n\u00E1vratu pravideln\u00E9ho menstrua\u010Dn\u00EDho krv\u00E1cen\u00ED.\nU 89% \u017Een, u nich\u017E byly b\u011Bhem lute\u00E1ln\u00ED f\u00E1ze monitorov\u00E1ny hladiny progesteronu, bylo prok\u00E1z\u00E1no \u00FAsp\u011B\u0161n\u00E9 obnoven\u00ED ovula\u010Dn\u00EDch cykl\u016F. U 90% \u017Een, trp\u00EDc\u00EDch galaktoreou, bylo dosa\u017Eeno terapeutick\u00E9ho efektu. U 50-90% \u017Een i mu\u017E\u016F s\u00A0mikro nebo makroprolaktinomy se poda\u0159ilo l\u00E9\u010Dbou redukovat n\u00E1dorovou masu.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 810.2100219726562 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 681.5700073242188 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 8X0.5MG" , "@language" : "cs" } ] }] }